Morgan J, Lottman H, Abbou C C, Chopin D K
Centre de Recherches Chirurgicales, Creteil, France.
Photochem Photobiol. 1994 Nov;60(5):486-96. doi: 10.1111/j.1751-1097.1994.tb05139.x.
There is a need to improve the selectivity of photodynamic therapy and for better targeting of tumor cells within specific tumor compartments. Selective in vitro phototoxicity of a human bladder carcinoma cell line 647V has been achieved by targeting sulfonated aluminum phthalocyanines (AlSPc) with monoclonal antibodies. Aluminum tetra-3 sulfonyl chloride phthalocyanine (PC) or rhodamine sulfonyl chloride were directly coupled to antibodies by a sulfonamide linkage and AlSPc or carboxyfluorescein were encapsulated in liposomes of the small unilamellar vesicle type (SUV) bearing antibody. Antibody E7 (IgM subclass), which recognized an antigenic determinant expressed on 647V but was absent on T24 a control human bladder carcinoma cell line, and a control IgM antibody were used. The effects of the two types of conjugate were compared. Immunofluorescence studies on living cells demonstrated specific cell surface localization of conjugates at 4 degrees C and internalization at 37 degrees C. Phototoxicity was measured by 3-(4,5-dimethylthiazol-2-5-diphenyltetrazolium) bromide assay after exposing AlSPc-sensitized cells to red light. Significant AlSPc dose-dependent phototoxicity of the order 4 degrees C < 4 degrees C plus 37 degrees C < 37 degrees C was observed with E7-SUV and E7-PC in the range 1-8 microM AlSPc. At equimolar AlSPc doses absolute toxicity was similar for the two conjugate types, but at equimolar antibody doses, the liposomal conjugate was more effective by up to 13-fold. Addition of urine during illumination decreased toxicity, which was attributed to the presence of protective elements. The results suggest that photosensitizers such as AlSPc could be used for antibody-directed therapy and in particular for selectively damaging tumor cells of the epithelial cell compartment in bladder carcinoma by intrabladder administration. The therapeutic ratio, which takes into account both specific and nonspecific toxicity, was greater for the liposome conjugate than for the direct conjugate indicating their greater suitability for in vivo instillation.
有必要提高光动力疗法的选择性,并更好地靶向特定肿瘤区域内的肿瘤细胞。通过用单克隆抗体靶向磺化铝酞菁(AlSPc),已实现了对人膀胱癌细胞系647V的体外选择性光毒性。四 - 3 - 磺酰氯铝酞菁(PC)或罗丹明磺酰氯通过磺酰胺键直接与抗体偶联,并且AlSPc或羧基荧光素被包裹在带有抗体的小单层囊泡型(SUV)脂质体中。使用了识别在647V上表达但在对照人膀胱癌细胞系T24上不存在的抗原决定簇的抗体E7(IgM亚类)和对照IgM抗体。比较了两种类型偶联物的效果。对活细胞的免疫荧光研究表明,偶联物在4℃时特异性定位于细胞表面,在37℃时内化。在用红光照射AlSPc致敏细胞后,通过3 -(4,5 - 二甲基噻唑 - 2 - 5 - 二苯基四氮唑)溴化物测定法测量光毒性。在1 - 8 microM AlSPc范围内,观察到E7 - SUV和E7 - PC具有显著的AlSPc剂量依赖性光毒性,顺序为4℃ < 4℃加37℃ < 37℃。在等摩尔AlSPc剂量下,两种偶联物类型的绝对毒性相似,但在等摩尔抗体剂量下,脂质体偶联物的效果高达13倍。光照期间添加尿液会降低毒性,这归因于保护成分的存在。结果表明,诸如AlSPc之类的光敏剂可用于抗体导向治疗,特别是通过膀胱内给药选择性地损伤膀胱癌上皮细胞区域的肿瘤细胞。考虑到特异性和非特异性毒性的治疗比率,脂质体偶联物比直接偶联物更大,表明它们更适合体内灌注。